---
$id: https://graph.org.ai/products/commodity/51182301
$type: Product
source: UNSPSC
code: "51182301"
title: "Somatrem"
class: "51182300"
classTitle: "Growth hormones and their inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Somatrem

**UNSPSC Code**: 51182301
**Class**: [Growth hormones and their inhibitors](Growth hormones and their inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pituitary agent with the molecular formula C995H1537N263O301S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CU8D464EDW, more generally known as somatrem. European Medicines Agency schedules somatrem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10583MIG. The term SOMATREM is an International Non-Proprietary Name or INN. SOMATREM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule somatrem under HS 29371100 and SITC 54154. As of Q4 2014, SOMATREM remains the US FDA Preferred Term for this commodity. Somatrem bears US NLM identifiers UMLS ID C0143083 and NCI Concept Code C66556. SMILES: NONE.

